药物坚持教育干预对2型糖尿病成人临床结果的影响:一项随机对照试验研究

相关实验视频

Updated: Jun 1, 2025

06:13

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health

Published on: December 1, 2023

1.0K

Ali Tarighat Esfanjani¹, Maryam Zare², Afrouz Mardi³

¹Professor of Nutrition, Nutrition Research Center, Faculty of Nutrition and Food Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.

Endocrine, metabolic & immune disorders drug targets

|January 21, 2025

概括

药物坚持教育显著改善了2型糖尿病 (T2DM) 的成年人的临床结果. 这项干预措施提高了葡萄糖控制和胰岛素敏感性,突出了患者教育对管理T2DM的重要性.

科学领域:

内分泌学在内分泌学.
糖尿病管理糖尿病管理
公共卫生公共卫生

背景情况:

在患有2型糖尿病 (T2DM) 的成年人中,口服抗糖尿病药物 (OAD) 的低坚持与严重的并发症,死亡率和增加的医疗负担有关.
需要有效的策略来改善T2DM患者的药物坚持.

研究的目的:

评估药物坚持教育干预措施对T2DM成人临床结果的有效性.
评估量身定制的教育课程对血糖控制,胰岛素抵抗和坚持行为的影响.

主要方法:

一项随机对照试验,涉及70名在伊朗阿尔达比尔T2DM的成年人.
参与者被分配到一个干预组 (n=35) 接受四次教育课程或一个非干预对照组 (n=35).
教育内容根据变化阶段 (SOC) 模型进行了调整;评估发生在基线,4周和6个月.

主要成果:

与对照组相比,干预组的禁食血葡萄糖 (FPG) 和2小时血葡萄糖 (2-hPG) 水平显著改善.
HbA1C水平显著降低,胰岛素抵抗评估的恒温模式 (HOMA-IR) 在干预组干预后显示胰岛素敏感性有所改善.
在随访时,干预组的OAD遵守变化阶段 (SOC) 显著改善.

结论:

药物坚持教育干预措施在改善T2DM成年人的临床结果方面表现有前途.
量身定制的教育方法,考虑行为变化模型,可以提高患者的坚持和血糖控制.
这些发现支持将全面的患者教育纳入T2DM管理策略.

关键词:

糖尿病是一种糖尿病.抗糖尿病药物可以治疗糖尿病.血糖控制血糖控制血糖控制药物治疗的坚持药物治疗的坚持这是一个超理论模型.

相关概念视频

01:15

Diabetes: Management and Pharmacotherapy

233

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

233

01:22

Diabetes Mellitus: Type 2 and Gestational

2.2K

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

2.2K

01:16

Insulin: Dosing Regimen and Adverse Effects

141

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

141

01:22

Diabetes Mellitus: Overview and Type I Subtype

2.4K

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

2.4K

01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

165

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...

165